Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
Although a high proportion of patients included in this study had HCV GT3b, cirrhosis, HCC, or HCV/HBV, HCV/HIV, or HCV/HBV/HIV coinfection, SOF/VEL ± RBV was highly effective and well tolerated in Chinese patients with CHC.
Authors
- En‐Qiang Chen (ORCID: https://orcid.org/0000-0002-8523-1689)
- Jiayi Wang (ORCID: https://orcid.org/0000-0003-2887-9283)
- Hong Tang (ORCID: https://orcid.org/0000-0003-2410-9177)
- Yilan Zeng (ORCID: https://orcid.org/0000-0001-5777-5702)
- Ning Han (ORCID: https://orcid.org/0000-0003-0920-9049)
- Han Chen (ORCID: https://orcid.org/0000-0003-0583-6213)
- Dongmei Zhang (ORCID: https://orcid.org/0000-0002-3111-8728)
- Miao Liu (ORCID: https://orcid.org/0000-0002-7975-6702)
- Xiaona Song
- Xing Cheng (ORCID: https://orcid.org/0000-0002-2389-2377)
- Chen Zhou
- Lingyao Du (ORCID: https://orcid.org/0000-0002-2688-4604)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Public Health Clinical Center of Chengdu (CN)
Publication Details
- Journal
- Journal of Virus Eradication
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.jve.2024.100571
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Gilead Sciences
- Sichuan University
- West China Hospital, Sichuan University
- NIH Clinical Center